Glycobiology Market to grow by USD 1.47 billion from 2022-2027 | North America to account for 43% of market growth – Technavio

NEW YORK, Sept. 21, 2023 /PRNewswire/ — The glycobiology market size is expected to grow by USD 1.47 billion from 2022 to 2027. In addition, the momentum of the market will progress at a CAGR of 15.06% during the forecast period, according to Technavio Research. The market has been segmented by Application (Drug discovery and development, Disease diagnostics, and Others), Product (Enzymes, Instruments, Reagents, and Kits), and Geography (North America, Europe, Asia, and Rest of World (ROW)). North America will contribute 43% to the growth of the global market during the forecast period. The regional market growth can be attributed to the presence of key pharmaceutical and biopharmaceutical companies. Furthermore, factors like the presence of well-established healthcare infrastructure and accessibility to advanced products also drive the regional glycobiology market. Also, the increasing application of glycans for various cancer treatments as well as increasing funding from government organizations to improve the field of glycobiology will fuel the market growth in the region during the forecast period. This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a PDF Sample Report

Company Profile:

Agilent Technologies Inc., Asparia Glycomics, Bio Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, ICE S.p.a., Lectenz Bio, Ludger Ltd., Merck KGaA, New England Biolabs Inc., NZYTech, Plexera LLC, Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., ZBiotech

Agilent Technologies Inc: The company offers glycobiology products such as glycobiology enzymes for N-glycan workflows.

•    To gain access to more vendor profiles available with Technavio,buy the report!

Glycobiology Market: Segmentation Analysis

By Segment – The drug discovery and development segment is significant during the forecast period. Carbohydrates play a major role in many biological processes, including acting as the most abundant molecule in the body, an energy source for glucose metabolism, or a structural cell wall component. Furthermore, various advances in mass spectrometry (MS) equipment will allow the mapping of glycan attachment sites, profiling of glycan structural variations, and determining detailed carbohydrate microstructures. Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a PDF Sample Report

“Besides analyzing the current market scenario, our report examines historic data from 2017 to 2021”- Technavio

Glycobiology Market: Driver & Trend:


  • Growing prevalence of cancer
  • Increase in expenditure by different pharmaceutical companies on R&D
  • Increasing government and private funding for glycomics and proteomics research

The increase in expenditure by different pharmaceutical companies on R&D drives the growth of the glycobiology market. Various pharmaceutical companies are investing in R&D which include glycomics & glycobiology as well as proteomics research. For instance, the average spending of pharmaceutical companies is about 15%-20% of their revenue for R&D purposes, which results in it bringing several products into the market. Hence, such factors drive the growth of the glycobiology market during the forecast period.

The growing demand for glycomics products for drug discovery and development is an emerging glycobiology market trend. Identify key trends, drivers, and challenges in the market. Download a sample report to gain access to this information.

Related Reports:

The global glycolic acid market size is estimated to grow by USD 154.05 million between 2022 and 2027 exhibiting a CAGR of 7.92%.

The Poly(lactic-co-glycolic acid) (PLGA) Market size is estimated to grow at a CAGR of 8.12% between 2022 and 2027. The market size is forecast to increase by USD 106.84 million.

What are the key data covered in this glycobiology market report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the glycobiology market between 2022 and 2027.
  • Precise estimation of the glycobiology market size and its contribution to the market in focus on the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the glycobiology market across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive analysis of factors that will challenge the growth of glycobiology market vendors.


Executive Summary

Market Landscape

Market Sizing

Historic Market Sizes

Five Forces Analysis

Market Segmentation by Application

Market Segmentation by Product

Market Segmentation by Geography

Customer Landscape

Geographic Landscape

Drivers, Challenges, & Trends

Company Landscape

Company Analysis


About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: [email protected]


SOURCE Technavio